We and others have reported that CD276 is overexpressed on a wide range of human solid tumors, including RMS15–17, and its overexpression is correlated with tumor progression, metastasis, and poor clinical outcome across a variety of malignancies18,19. The gene discussed is CD276; the disease is neoplasm.